A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Dabigatran impurity H | Dabigatran impurity H. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: ethyl 3-(1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate. CAS No. 1702936-92-2. Molecular formula: C19H20N4O3. Mole weight: 352.39. Catalog: APB1702936922. |  |
| Dabigatran Impurity H | Des-(N-2-pyridyl-β-alanine ethyl ester) Dabigatran etexilate 5-ethyl carboxylate is a derivative of Dabigatran, an oral thrombin inhibitor used to prevent venous thromboembolism. Synonyms: Des-(N-2-pyridyl-β-alanine Ethyl Ester) Dabigatran Etexilate 5-Ethyl Carboxylate; 2- [ [ [4- [ [ [ (Hexyloxy) carbonyl] amino] iminomethyl] phenyl] amino] methyl] -1-methyl-1H-benzimidazole-5-carboxylic Acid Ethyl Ester. Grades: > 95%. CAS No. 1408238-36-7. Molecular formula: C26H33N5O4. Mole weight: 479.57. |  |
| Dabigatran impurity I | Cas No. 211915-84-3. | |
| Dabigatran Impurity K | An impurity of Dabigatran, an anticoagulant used to treat and prevent blood clots. Grades: > 95%. CAS No. 211915-00-3. Molecular formula: C33H39N7O5. Mole weight: 613.72. | |
| Dabigatran impurity M | Dabigatran impurity M. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: ethyl 2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-1H-benzo[d]imidazole-5-carboxylate. CAS No. 1408238-41-4. Molecular formula: C19H21N5O2. Mole weight: 351.4. Catalog: APB1408238414. | |
| Dabigatran Impurity M | Dabigatran Carboxamide Ethyl Ester is an impurity of Dabigatran Etexilate Mesylate which is a nonpeptide, direct thrombin inhibitor. Synonyms: Dabigatran Carboxamide Ethyl Ester. Grades: > 95%. CAS No. 1422435-41-3. Molecular formula: C27H28N6O4. Mole weight: 500.55. | |
| Dabigatran impurity P | Cas No. 212322-56-0. | |
| Dabigatran Isopropyl Ester Impurity | Dabigatran Isopropyl Ester Impurity is an impurity of Dabigatran, an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. CAS No. 1610758-17-2. Molecular formula: C28H31N7O3. Mole weight: 513.6. | |
| Dabigatran Methyl Ester Impurity | Dabigatran Methyl Ester Impurity is an impurity of Dabigatran, an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. CAS No. 771459-37-1. Molecular formula: C26H27N7O3. Mole weight: 485.55. | |
| Dabigatran tert-Butylcarbonyl Acetate 6-Benzyloxy Acyl- β-D-Glucuronide | Dabigatran tert-Butylcarbonyl Acetate 6-Benzyloxy Acyl- β-D-Glucuronide. Group: Biochemicals. Alternative Names: (2S,3R,4S,5S,6S)-6-(Benzyloxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl 3- (2- ( ( (4- ( (Z) -N'-acetoxycarbamimidoyl) phenyl) (tert-butoxycarbonyl) amino) methyl) -1-methyl-N- (pyridin-2-yl) -1H-benzo[d]imidazole-5-carboxamido) propanoate. Grades: Highly Purified. Pack Sizes: 2.5mg. US Biological Life Sciences. |  Worldwide |
| Dabigatran tert-Butylcarbonyl Acetate 6-Benzyloxy Acyl-β-D-Glucuronide | Dabigatran tert-Butylcarbonyl Acetate 6-Benzyloxy Acyl-β-D-Glucuronide is a protected major metabolite of Dabigatran, an nonpeptide, direct thrombin inhibitor. Synonyms: (2S,3R,4S,5S,6S)-6-(Benzyloxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl 3-(2-(((4-((Z)-N'-acetoxycarbamimidoyl)phenyl)(tert-butoxycarbonyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate. Molecular formula: C44H49N7O12. Mole weight: 867.9. | |
| DABNA-1 | DABNA-1. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 5,9-diphenyl-5H,9H-[1,4]Benzazaborino[2,3,4-kl]phenazaborine. Product Category: Organic Light Emitting Diode (OLED). CAS No. 1689552-89-3. Molecular formula: C30H21BN2. Mole weight: 420.31 g/mol. Product ID: ACM1689552893. Alfa Chemistry ISO 9001:2015 Certified. Categories: Darna (1991 film). |  |
| Dabrafenib | Dabrafenib (GSK2118436A) is an ATP-competitive inhibitor of Raf with IC 50 s of 5 nM and 0.6 nM for C-Raf and B-Raf V600E , respectively [4]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: GSK2118436A; GSK2118436. CAS No. 1195765-45-7. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg; 200 mg; 500 mg; 1 g. Product ID: HY-14660. |  |
| Dabrafenib Mesylate | Dabrafenib, also known as GSK2118436, is an orally bioavailable inhibitor of B-raf (BRAF) protein with potential antineoplastic activity. Dabrafenib selectively binds to and inhibits the activity of B-raf, which may inhibit the proliferation of tumor cells which contain a mutated BRAF gene. B-raf belongs to the the raf/mil family of serine/threonine protein kinases and plays a role in regulating the MAP kinase/ERKs signaling pathway, which may be constitutively activated due to BRAF gene mutations. On May 29, 2013, FDA approved this drug. Synonyms: N-(3-(5-(2-aminopyrimidin-4-yl)-2-(tert-butyl)thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide methanesulfonate; Dabrafenib mesylate; GSK 2118436B; GSK2118436B; GSK-2118436B; GSK2118436 Methane sulfonate salt; Brand name: Taflinar. Grades: >98%. CAS No. 1195768-06-9. Molecular formula: C24H24F3N5O5S3. Mole weight: 615.67. | |
| Dabrafenib Mesylate | Dabrafenib Mesylate is a potent and selective Raf kinase inhibitor with IC 50 s of 0.6 and 5.0 nM for Raf V600E and c-Raf, respectively. Uses: Scientific research. Group: Signaling pathways. Alternative Names: GSK2118436 Mesylate; GSK 2118436B. CAS No. 1195768-06-9. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg; 500 mg. Product ID: HY-14660A. | |
| D-(+)-a-Bromocamphor-8-sulfonic acid ammonium salt | D-(+)-a-Bromocamphor-8-sulfonic acid ammonium salt. Group: Biochemicals. Alternative Names: (1S,2S,4R,7R)-2-Bromo-4,7-dimethyl-3-oxo-bicyclo[2.2.1]heptane-7-methanesulfonic acid ammonium salt; Ammonium (+)-3-bromo-8-camphorsulfonate; [1S-(endo,anti)]-3-bromo-1,7-dimethyl-2-oxo-bicyclo[2.2.1]heptane-7-methanesulfonic acid ammonium salt. Grades: Highly Purified. CAS No. 14575-84-9. Pack Sizes: 5g, 10g, 25g, 50g, 100g. Molecular Formula: C10H18BrNO4S. US Biological Life Sciences. | Worldwide |
| Dabsylaminoethyl Methanethiosulfonate | A fluorescent sulfhydryl active reagent. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| DABSYL chloride | DABSYL chloride. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 4-Dimethylaminoazobenzene-4-sulfonylchloride. Product Category: Other Fluorophores. CAS No. 56512-49-3. Molecular formula: C14H14ClN3O2S. Mole weight: 323.8. Purity: 95%+. IUPACName: 4-[[4-(dimethylamino)phenyl]diazenyl]benzenesulfonylchloride. Canonical SMILES: CN(C)C1=CC=C(C=C1)N=NC2=CC=C(C=C2)S(=O)(=O)Cl. Density: 1.29 ± 0.1 g/ml. Product ID: ACM56512493-1. Alfa Chemistry ISO 9001:2015 Certified. Categories: Dansyl chloride. | |
| DACA | DACA inhibits two essential nuclear enzymes in vitro, DNA topoisomerase I and DNA topoisomerase (topo) II. DACA stabilises topo I, topo II alpha, and topo II beta cleavable complexes in human leukaemia CCRF-CEM cells [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 89459-25-6. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-100777. | |
| Dacanal | Decanal is an aliphatic reagent used in the preparation of a new class of antibacterials resulting from erythromycin derivatives. Also used in the preparation of 2,4-disubstituted pyrrolidines from aldehydes. Group: Biochemicals. Grades: Highly Purified. CAS No. 112-31-2. Pack Sizes: 50g, 100g, 250g, 500g, 1kg. Molecular Formula: C??H??O, Molecular Weight: 156.27. US Biological Life Sciences. | Worldwide |
| Dacarbazine | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standardsapi standardsbritish pharmacopoeiaeuropean pharmacopoeia (ph. eur.)pharmaceutical toxicologypharmacopoeial standards. Alternative Names: Deticene, 4(or 5)-(3,3-Dimethyl-1-triazeno)imidazole-5(or 4)-carboxamide, (Dimethyltriazeno)imidazolecarboxamide, ICDMT, Imidazole-4(or 5)-carboxamide, 5(or 4)-(3,3-dimethyl-1-triazeno)- (7CI), 5(or 4)-(3,3-Dimethyl-1-triazeno)imidazole-4(or 5)carboxamide, 5-(Dimethyltriazeno)imidazole-4-carboxamide, Biocarbazine R, Dacarbasine, DIC, DTIC, 5(4)-(3,3-Dimethyl-1-triazeno)imidazole-4(5)-carboxamide, 5-(3,3'-Dimethyl-1-triazeno)imidazole-4-carboxamide,1H-Imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazen-1-yl)-, DTIC-Dome, ICDT, 4-(Dimethyltriazeno)imidazole-5-carboxamide, NCI C04717, 5-(3,3-Dimethyltriazeno)imidazole-4-carboxamide, Dacarbazine, DTIE, Imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazeno)- (8CI), 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide, 5-(3,3-Dimethyl-1-triazenyl)-1H-imidazole-4-carboxamide, Detimedac, 1H-Imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazenyl)- (9CI), 5-(3,3-Dimethyl-1-triazenyl)imidazole-4-carboxamide, NSC 45388. | |
| Dacarbazine | Dacarbazine. Group: Biochemicals. Grades: Highly Purified. CAS No. 4342-3-4. Pack Sizes: 500mg, 1g, 2g, 5g. US Biological Life Sciences. | Worldwide |
| Dacarbazine | 100mg Pack Size. Group: Bioactive Small Molecules, Research Organics & Inorganics. Formula: C6H10N6O. CAS No. 4342-3-4. Prepack ID 26535422-100mg. Molecular Weight 182.18. See USA prepack pricing. |  |
| Dacarbazine | Dacarbazine is an antineoplastic chemotherapy drug used in the treatment of various cancers.Dacarbazine is a member of the class of alkylating agents, which destroy cancer cells by adding an alkyl group (CnH2n+1) to its DNA. Uses: Anti-tumor. Synonyms: DTIC-Dome. Grades: >98%. CAS No. 4342-3-4. Molecular formula: C6H10N6O. Mole weight: 182.18. | |
| Dacarbazine | Dacarbazine is a nonspecific antineoplastic ( antineoplastic ) alkylating agent. Dacarbazine inhibits T and B lymphocyte responses with IC 50 of 50 and 10 μg/mL, respectively. Dacarbazine can be used in the study of metastatic malignant melanoma [1] [2] [3] [4] [5]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: Imidazole Carboxamide. CAS No. 4342-3-4. Pack Sizes: 10 mM * 1 mL; 50 mg; 100 mg; 200 mg; 1 g. Product ID: HY-B0078. | |
| Dacarbazine | Dacarbazine is a cell cycle nonspecific antineoplastic alkylating agent. Dacarbazine inhibits T and B lymphoblastic response, with IC50 values of 50 and 10 μg/ml, respectively. Dacarbazine can be used for the research of metastatic malignant melanoma. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 4-(3,3-Dimethyl-1-triazeno)imidazole-5-carboxamide. Product Category: Inhibitors. Appearance: White powder. CAS No. 4342-3-4. Molecular formula: C6H10N6O. Mole weight: 182.18. Purity: 0.98. IUPACName: 4-[(E)-dimethylaminodiazenyl]-1H-imidazole-5-carboxamide. Canonical SMILES: CN(C)/N=N/C1=C(NC=N1)C(=O)N. Density: 1.32 g/ml. Product ID: ACM4342034. Alfa Chemistry ISO 9001:2015 Certified. | |
| Dacarbazine (5-(3,3-Dimethyl-1-triazenyl)imidazole-4-carboxamide, DTIC, DIC, NSC-45388) | Used as an antineoplastic. Used in the treatment of malignant melanoma and sarcomas. Group: Biochemicals. Alternative Names: 5-(3,3-Dimethyl-1-triazenyl)imidazole-4-carboxamide, DTIC, DIC, NSC-45388. Grades: Highly Purified. Pack Sizes: 1g. US Biological Life Sciences. | Worldwide |
| Dacarbazine-d6 | Labeled Dacarbazine. Dacarbazine is used as an antineoplastic for treatment of malignant melanoma and sarcomas. Group: Biochemicals. Alternative Names: 5-[3,3-Di-(methyl-d3)-1-triazenyl]imidazole-4-carboxamide; DTIC-d6; DIC-d6; NSC-45388-d6; Dacatic-d6; Deticene-d6. Grades: Highly Purified. CAS No. 1185241-28-4. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Dacarbazine-d6 | Dacarbazine-d6 is the deuterium labeled Dacarbazine. Dacarbazine(DTIC-Dome; DTIC) is an antineoplastic agent. It has significant activity against melanomas. Uses: Designed for use in research and industrial production. Additional or Alternative Names: Dacarbazine-D6;5-[3,3-Di-(methyl-d3)-1-triazenyl]imidazole-4-carboxamide;Dacatic-d6;Deticene-d6;DIC-d6;DTIC-d6;NSC-45388-d6. Product Category: Inhibitors. Appearance: Pink Solid. CAS No. 1185241-28-4. Molecular formula: C6H4D6N6O. Mole weight: 188.22. Purity: 99 atom % D. Canonical SMILES: [2H]C([2H])([2H])N(C([2H])([2H])[2H])/N=N/C1=C(N=CN1)C(N)=O. Product ID: ACM1185241284. Alfa Chemistry ISO 9001:2015 Certified. | |
| Dacarbazine Impurity A | 2-Azahypoxanthine, is an impurity of Dacarbazine, which is used as an antineoplastic for treatment of various cancers such as, malignant melanoma and sarcomas. Synonyms: 2-Azahypoxanthine; 3,7-Dihydro-4H-imidazo[4,5-d]-1,2,3-triazin-4-one; 1,5-Dihydro-4H-Imidazo[4,5-d]-1,2,3-triazin-4-one; 3,7-Dihydro-4H-imidazo[4,5-d]-v-triazin-4-one. Grades: > 95%. CAS No. 4656-86-4. Molecular formula: C4H3N5O. Mole weight: 137.1. | |
| Dacarbazine Related Compound A | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Dacarbazine Related Compound B | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Dacarbazine USP | Dacarbazine USP. Grades: USP. CAS No. 4342-3-4. Product ID: 8-04531. Molecular formula: C6H10N6O. Mole weight: 18218. |  |
| DACB-CN | DACB-CN. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 4-(7-Diethylaminocoumarin-3-yl)benzoylcyanide. Product Category: Other Fluorophores. Appearance: Solid. CAS No. 203256-20-6. Molecular formula: C21H18N2O3. Mole weight: 346.38. Purity: 90%+. IUPACName: 4-[7-(diethylamino)-2-oxochromen-3-yl]benzoylcyanide. Canonical SMILES: CCN(CC)C1=CC2=C(C=C1)C=C(C(=O)O2)C3=CC=C(C=C3)C(=O)C#N. Product ID: ACM203256206-2. Alfa Chemistry ISO 9001:2015 Certified. Categories: 4-(7-Diethylaminocoumarin-3-yl)benzoyl cyanide. | |
| Dacemazine | Dacemazine. Uses: Designed for use in research and industrial production. Additional or Alternative Names: dacemazine;10-(Dimethylamino)acetyl-10H-phenothiazine;10-(N,N-Dimethylglycyl)-10H-phenothiazine;10-[(Dimethylamino)acetyl]-10H-phenothiazine;Ahistan;Histantin Richter);2-(dimethylamino)-1-phenothiazin-10-ylethanone;2-(dimethylamino)-1-phenothiazin-10-yl-. Product Category: Heterocyclic Organic Compound. CAS No. 518-61-6. Molecular formula: C16H16N2OS. Mole weight: 284.381. Density: 1.246g/cm³. Product ID: ACM518616. Alfa Chemistry ISO 9001:2015 Certified. | |
| Dacetuzmumab | Cas No. 880486-59-9. | |
| Dacetuzumab | Dacetuzumab (SGN-40) is a humanized IgG1, anti-CD40 monoclonal antibody with anti-lymphoma activity. Dacetuzumab kills tumor cells via immune effector functions (antibody-dependent cellular cytotoxicity and phagocytosis [ADCC/ADCP]). Dacetuzumab ((SGN-40) can be used for multiple myeloma research [1]. Uses: Scientific research. Group: Inhibitory antibodies. CAS No. 880486-59-9. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99015. | |
| Dacinostat | Dacinostat, also known as LAQ824, is a hydroxamate histone deacetylase inhibitor with potential anticancer activity. LAQ824 sensitized nonsmall cell lung cancer to the cytotoxic effects of ionizing radiation. LAQ824 reduced clonogenic survival of the H23 and H460 cell lines five-fold compared with controls and four-fold compared with either agent alone (P<0.001). In phase I trials, LAQ824 was well tolerated at doses that induced accumulation of histone acetylation, with higher doses inducing changes consistent with HSP90 inhibition. Synonyms: NVP-LAQ824; NVP LAQ824; LAQ-824; LAQ824; LAQ 824; Dacinostat. CAS No. 404951-53-7. Molecular formula: C22H25N3O3. Mole weight: 379.46. | |
| Dacitracin | Dacitracin. CAS No. 1405-87-4. Product ID: 8-01443. Molecular formula: C63H98N14O14S. Mole weight: 1307.62. | |
| Daclatasvir | Daclatasvir, inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). Synonyms: Daclatasvir; BMS-790052; BMS 790052; BMS790052; EBP-883; EBP 883; EBP883; trade name Daklinza. Grades: 0.98. CAS No. 1009119-64-5. Molecular formula: C40H50N8O6. Mole weight: 738.89. | |
| Daclatasvir | Daclatasvir (BMS-790052) is a potent and orally active HCV NS5A protein inhibitor with EC 50 s range of 9-146 pM for multiple HCV replicon genotypes. Daclatasvir is also a organic anion transporting polypeptide 1B (OATP1B) and OATP1B3 inhibitor with IC 50 s of 1.5 μM and 3.27 μM, respectively [1] [2] [3]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: BMS-790052; EBP 883. CAS No. 1009119-64-5. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg; 200 mg; 500 mg. Product ID: HY-10466. | |
| Daclatasvir | Daclatasvir. Group: Biochemicals. Grades: Highly Purified. CAS No. 1009119-64-5. Pack Sizes: 5mg, 10mg, 25mg, 50mg, 100mg. US Biological Life Sciences. | Worldwide |
| Daclatasvir Diethyl Ester-d10 | Daclatasvir Diethyl Ester-d10 is the isotope labelled analog of Daclatasvir Diethyl Ester (D101525); an impurity of Daclatasvir (D101500) which is a compound that inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg, 5mg. Molecular Formula: C42H44D10N8O6, Molecular Weight: 776.99. US Biological Life Sciences. | Worldwide |
| Daclatasvir dihydrochloride | Daclatasvir is a highly selective inhibitor of HCV NS5A with EC50 of 9-50 pM, for a broad range of HCV replicon genotypes and the JFH-1 genotype 2a infectious virus in cell culture. Synonyms: Methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate dihydrochloride; Daclatasvir; BMS790052; BMS 790052; BMS-790052; EBP883; EBP 883; EBP-883; Daklinza. Grades: >98%. CAS No. 1009119-65-6. Molecular formula: C40H50N8O6·2HCl. Mole weight: 811.8. | |
| Daclatasvir dihydrochloride | Daclatasvir dihydrochloride (BMS-790052 dihydrochloride) is a potent and orally active HCV NS5A protein inhibitor with EC 50 s range of 9-146 pM for multiple HCV replicon genotypes. Daclatasvir dihydrochloride is also an organic anion transporting polypeptide 1B (OATP1B) and OATP1B3 inhibitor with IC 50 s of 1.5 μM and 3.27 μM, respectively [1] [2] [3]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: BMS-790052 dihydrochloride; EBP 883 dihydrochloride. CAS No. 1009119-65-6. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-10465. | |
| Daclatasvir Impurity 10 | Daclatasvir Impurity 10. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1009119-83-8. Molecular formula: C26H29ClN6. Mole weight: 461.01. Catalog: APB1009119838. | |
| Daclatasvir Impurity 11 | Daclatasvir Impurity 11. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1007882-23-6. Molecular formula: C36H44N6O4. Mole weight: 624.79. Catalog: APB1007882236. | |
| Daclatasvir Impurity 1 (RSSS-Isomer) | Daclatasvir Impurity 1 (RSSS-Isomer). Uses: For analytical and research use. Group: Impurity standards. Alternative Names: dimethyl ((2S,2'R)-((2S,2'S)-2,2'-(5,5'-([1,1'-biphenyl]-4,4'-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl))dicarbamate. CAS No. 1417333-83-5. Molecular formula: C40H50N8O6. Mole weight: 738.88. Catalog: APB1417333835. | |
| Daclatasvir Impurity 1 (SRSS-Isomer) | Daclatasvir Impurity 1 (SRSS-Isomer). Uses: For analytical and research use. Group: Impurity standards. Alternative Names: Daclatasvir Impurity 1 (SRSS-Isomer). CAS No. 1009117-28-5. Molecular formula: C40H50N8O6. Mole weight: 738.88. Catalog: APB1009117285. | |
| Daclatasvir Impurity 4 | Daclatasvir Impurity 4. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1009117-26-3. Molecular formula: C40H50N8O6. Mole weight: 738.89. Catalog: APB1009117263. | |
| Daclatasvir Impurity 4 | Daclatasvir RSSR Isomer is an isomer of Daclatasvir, a compound that inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). Synonyms: Daclatasvir RSSR Isomer; N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1R)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic Acid C,C'-Dimethyl Ester. Grades: > 95%. CAS No. 1009107-27-0. Molecular formula: C40H50N8O6. Mole weight: 738.88. | |
| Daclatasvir Impurity 5 | Daclatasvir Impurity 5. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1009107-27-0. Molecular formula: C40H50N8O6. Mole weight: 738.89. Catalog: APB1009107270. | |
| Daclatasvir Impurity 6 | Daclatasvir SRRS Isomer is an isomer of Daclatasvir, a compound that inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). Synonyms: Daclatasvir SRRS Isomer; N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2R)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic Acid C,C'-Dimethyl Ester. Grades: > 95%. CAS No. 1009117-26-3. Molecular formula: C40H50N8O6. Mole weight: 738.88. | |
| Daclatasvir Impurity 9 | Daclatasvir Impurity 9. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1007884-60-7. Molecular formula: C33H39N7O3. Mole weight: 581.72. Catalog: APB1007884607. | |
| Daclizumab | Daclizumab is a humanized monoclonal antibody of the human IgG1 isotype that binds specifically to the Tac epitope on the α-subunit (CD25) of the IL-2R. Synonyms: Zenapax; Ro 24-7375. CAS No. 152923-56-3. Molecular formula: C6332H9808N1678O1989S42. Mole weight: 142612.1. | |
| Daclizumab | Daclizumab (Zenapax) is a humanized, monoclonal antibody that blocks CD25 (α-subunit of the high-affinity interleukin-2 receptor (IL-2R-HA)). Daclizumab (Zenapax) reversibly binds to CD25and prevents the interaction of IL-2 with the IL-2R-HA. Daclizumab (Zenapax) can be used for multiple sclerosis research [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: Zenapax; Ro 24-7375. CAS No. 152923-56-3. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-108738. | |
| DACM | DACM (N-(7-Dimethylamino-4-methyl-3-coumarinyl)maleimide) is a thiol-directed fluorescent dye (Ex=396 nm, Em=468 nm) [1]. Uses: Scientific research. Group: Fluorescent dye. Alternative Names: N-(7-Dimethylamino-4-methyl-3-coumarinyl)maleimide. CAS No. 55145-14-7. Pack Sizes: 1 mg. Product ID: HY-121030. | |
| DACM | DACM. Uses: Designed for use in research and industrial production. Additional or Alternative Names: N-(7-Dimethylamino-4-methylcoumarin-3-yl)maleimide. Product Category: Other Fluorophores. Appearance: Orange solid. CAS No. 55145-14-7. Molecular formula: C16H14N2O4. Mole weight: 298.29. Purity: 98%+. IUPACName: 1-[7-(dimethylamino)-4-methyl-2-oxochromen-3-yl]pyrrole-2,5-dione. Canonical SMILES: CC1=C(C(=O)OC2=C1C=CC(=C2)N(C)C)N3C(=O)C=CC3=O. Product ID: ACM55145147-1. Alfa Chemistry ISO 9001:2015 Certified. Categories: N-(7-Dimethylamino-4-methyl-3-coumarinyl)maleimide, Dachshund. | |
| Dacomitinib | Dacomitinib, aslo known as PF-299 and PF-00299804; or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Dacomitinib specifically and irreversibly binds to and inhibits human EGFR subtypes, resulting in inhibition of proliferation and induction of apoptosis in EGFR-expressing tumor cells. EGFRs play major roles in tumor cell proliferation and tumor vascularization, and are often overexpressed or mutated in various tumor cell types. Synonyms: dacomitinib; PF-00299804; PF00299804; PF 00299804; PF299804; PF-299804; PF 299804; PF-299; PF 299; PF299. CAS No. 1110813-31-4. Molecular formula: C24H25ClFN5O2. Mole weight: 469.945. | |
| Dacomitinib | Dacomitinib (PF-00299804) is a specific and irreversible inhibitor of the ERBB family of kinases with IC 50 s of 6 nM, 45.7 nM and 73.7 nM for EGFR , ERBB2 , and ERBB4 , respectively [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: PF-00299804; PF-299804. CAS No. 1110813-31-4. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg; 200 mg. Product ID: HY-13272. | |
| Dacomitinib hydrate | Dacomitinib (PF-00299804) hydrate is an orally active, irreversible pan- ErbB inhibitor. Dacomitinib hydrate can be used in the research of cancers such as metastatic non-small cell lung cancer (NSCLC) [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: PF-00299804 hydrate; PF-299804 hydrate. CAS No. 1042385-75-0. Pack Sizes: 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-118263. | |
| Dacomitinib Hydrate | Dacomitinib is a second-generation small molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) tyrosine kinase family (ErbB family) with potential anti-tumor activity. Uses: Tyrosine kinase inhibitors. Synonyms: PF-00299804; PF00299804; PF 00299804; PF299804. CAS No. 1042385-75-0. Molecular formula: C24H25ClFN5O2.H2O. Mole weight: 487.96. | |
| Dacomitinib Impurity 11 | Dacomitinib Impurity 11. Uses: For analytical and research use. Group: Impurity standards. CAS No. 13991-36-1. Molecular formula: C4H5BrO2. Mole weight: 164.99. Catalog: APB13991361. | |
| Dacomitinib Impurity 2F3L | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C24H25ClFN5O2. Mole weight: 469.95. | |
| Dacomitinib Impurity 3F4L | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C24H25ClFN5O2. Mole weight: 469.95. | |
| Dacomitinib Impurity 3F4LAJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C15H12ClFN4O. Mole weight: 318.73. | |
| Dacomitinib Impurity 3F4LXJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C15H10ClFN4O3. Mole weight: 348.72. | |
| Dacomitinib Impurity BDS | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C19H16ClFN4O2. Mole weight: 386.81. | |
| Dacomitinib Impurity C | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. CAS No. 869199-69-9. Molecular formula: C25H27ClFN5O2. Mole weight: 483.97. | |
| Dacomitinib Impurity D | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. CAS No. 869199-67-7. Molecular formula: C26H29ClFN5O2. Mole weight: 497.99. | |
Our database is helping our users find suppliers everyday.
